Cibc World Markets Corp Astrazeneca PLC Transaction History

Cibc World Markets Corp

$16.6 Billion
Q4 2024

A detailed history of Cibc World Markets Corp transactions in Astrazeneca PLC stock. As of the latest transaction made, Cibc World Markets Corp holds 12,901 shares of AZN stock, worth $937,386. This represents 0.01% of its overall portfolio holdings.

Number of Shares

12,901

Previous 12,759 1.11%

Holding current value

$937,386

Previous $994,000 14.99%

% of portfolio

0.01%

Previous 0.01%

11 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2024 Feb 10, 2025	BUY	$63.2 - $79.58 $8,974 - $11,300	142 Added 1.11%	12,901 $845,000
Q3 2024 Nov 13, 2024	SELL	$76.67 - $87.62 $2.25 Million - $2.57 Million	-29,353 Reduced 69.7%	12,759 $994,000
Q2 2024 Aug 12, 2024	BUY	$66.81 - $80.83 $251,806 - $304,648	3,769 Added 9.83%	42,112 $3.28 Million
Q1 2024 May 13, 2024	SELL	$61.03 - $69.57 $2.76 Million - $3.15 Million	-45,241 Reduced 54.13%	38,343 $2.6 Million
Q4 2023 Feb 13, 2024	BUY	$61.89 - $69.28 $1.03 Million - $1.15 Million	16,568 Added 24.72%	83,584 $5.63 Million
Q3 2023 Nov 13, 2023	BUY	$64.85 - $71.7 $1.13 Million - $1.25 Million	17,452 Added 35.21%	67,016 $4.54 Million
Q2 2023 Aug 04, 2023	BUY	$69.91 - $75.81 $2.96 Million - $3.21 Million	42,330 Added 585.15%	49,564 $3.55 Million
Q1 2023 May 11, 2023	SELL	$63.15 - $71.6 $1,894 - $2,148	-30 Reduced 0.41%	7,234 $502,000
Q4 2022 Feb 09, 2023	BUY	$54.21 - $70.44 $393,781 - $511,676	7,264 New	7,264 $492,000
Q2 2022 Aug 12, 2022	BUY	$59.26 - $71.14 $929,730 - $1.12 Million	15,689 Added 95.01%	32,202 $2.13 Million
Q1 2022 May 13, 2022	BUY	$55.72 - $67.12 $920,104 - $1.11 Million	16,513 New	16,513 $1.1 Million

Others Institutions Holding AZN

# of Institutions

1,352

Shares Held

478M

Call Options Held

5.39M

Put Options Held

3.75M

View Full List

About ASTRAZENECA PLC

Ticker AZN
Exchange OTC
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 3,099,020,032
Market Cap $225B
Description
AstraZeneca PLC, a biopharmaceutical company, focuses on the discovery, development, manufacturing, and commercialization of prescription medicines. Its marketed products include Calquence, Enhertu, Faslodex, Imfinzi, Iressa, Koselugo, Lumoxiti, Lynparza, Orpathys, Tagrisso, and Zoladex for oncology; Brilinta/Brilique, Bydureon/Byetta, BCise, By...

More about AZN

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Cibc World Markets Corp, based on Form 13F filings with the SEC.

News

Stay updated on Cibc World Markets Corp with notifications on news.

Account

Cibc World Markets Corp Astrazeneca PLC Transaction History